1. Home
  2. EVM vs CYBN Comparison

EVM vs CYBN Comparison

Compare EVM & CYBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVM
  • CYBN
  • Stock Information
  • Founded
  • EVM 2002
  • CYBN 2019
  • Country
  • EVM United States
  • CYBN Canada
  • Employees
  • EVM N/A
  • CYBN N/A
  • Industry
  • EVM Finance/Investors Services
  • CYBN Pharmaceuticals and Biotechnology
  • Sector
  • EVM Finance
  • CYBN Health Care
  • Exchange
  • EVM Nasdaq
  • CYBN Nasdaq
  • Market Cap
  • EVM 233.7M
  • CYBN 229.8M
  • IPO Year
  • EVM N/A
  • CYBN N/A
  • Fundamental
  • Price
  • EVM $9.45
  • CYBN $11.62
  • Analyst Decision
  • EVM
  • CYBN Strong Buy
  • Analyst Count
  • EVM 0
  • CYBN 3
  • Target Price
  • EVM N/A
  • CYBN $45.50
  • AVG Volume (30 Days)
  • EVM 55.8K
  • CYBN 334.2K
  • Earning Date
  • EVM 01-01-0001
  • CYBN 11-13-2024
  • Dividend Yield
  • EVM 4.01%
  • CYBN N/A
  • EPS Growth
  • EVM N/A
  • CYBN N/A
  • EPS
  • EVM 0.20
  • CYBN N/A
  • Revenue
  • EVM N/A
  • CYBN N/A
  • Revenue This Year
  • EVM N/A
  • CYBN N/A
  • Revenue Next Year
  • EVM N/A
  • CYBN N/A
  • P/E Ratio
  • EVM $47.61
  • CYBN N/A
  • Revenue Growth
  • EVM N/A
  • CYBN N/A
  • 52 Week Low
  • EVM $7.67
  • CYBN $6.50
  • 52 Week High
  • EVM $9.59
  • CYBN $21.66
  • Technical
  • Relative Strength Index (RSI)
  • EVM 56.53
  • CYBN 58.44
  • Support Level
  • EVM $9.25
  • CYBN $10.26
  • Resistance Level
  • EVM $9.36
  • CYBN $12.80
  • Average True Range (ATR)
  • EVM 0.08
  • CYBN 1.00
  • MACD
  • EVM 0.03
  • CYBN 0.05
  • Stochastic Oscillator
  • EVM 94.03
  • CYBN 60.10

About EVM Eaton Vance California Municipal Bond Fund of Beneficial Interest $.01 par value

Eaton Vance California Municipal Bond Fund is an investment company with an objective to provide current income exempt from regular federal income tax, including alternative minimum tax, and, in state specific funds, taxes in its specified state. The company provides its solutions to individual investors, institutional investors, high net worth individuals, family office investors, and financial professionals. It offers a range of equity, income and alternative strategies to institutional investors, both in the United States and internationally.

About CYBN Cybin Inc.

Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions.

Share on Social Networks: